A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors
Clinical trial NCT02988960 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02988960
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-22
- Primary completion
- 2026-09-01
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.